Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /NATCAPSUQ

Natural Capsules Ltd.

NATCAPSUQ

• NSE: NATCAPSUQ • Delayed

154.00INR -1.4%

1.61 USD

As of 6 June 2026, Natural Capsules Ltd. has a market cap of $16.92M USD, ranking #38253 globally and #2782 in India. It ranks #3413 in the Healthcare sector, and #217 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

38253

Country Rank

2782

Sector Rank

3413

Industry Rank

217

Key Stats

Market Cap

$16.92MUSD

1.62B INR

Enterprise Value

$30.13MUSD

2.87B INR

Revenue (TTM)

$18.14MUSD

1.74B INR

EBITDA (TTM)

-$475.29KUSD

-45.33M INR

Net Income (TTM)

-$2.0MUSD

-191.66M INR

EBITDA Margin

-2.6%

Profit Margin

-11%

PS Ratio

0.9

PB Ratio

0.7

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Sunil Laxminarayana Mundra open_in_new

Employees

619

Founded

1993

Website

naturalcapsules.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.4%	-2.8%	8.8%	-5.7%	-28%	-5.9%	-23%	-41%	-41%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	NATCAPSUQ Natural Capsules Ltd Shs Dematerialised ISIN: INE936B01015 Shares Out.: Shares Outstanding: 10.386M¹ Shares Float: 4.497M² TV: TradingView: NSE: NATCAPSUQ SA: Stock Analysis: NSE: NATCAPSUQ YF: Yahoo Finance: NATCAPSUQ.NS GF: Google Finance: NSE: NATCAPSUQ BA: Barron's: NATCAPSUQ MS: Morningstar: XNSE: NATCAPSUQ	154.00 INR	TV: TradingView: NSE: NATCAPSUQ SA: Stock Analysis: NSE: NATCAPSUQ YF: Yahoo Finance: NATCAPSUQ.NS GF: Google Finance: NSE: NATCAPSUQ BA: Barron's: NATCAPSUQ MS: Morningstar: XNSE: NATCAPSUQ
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	524654 (NATCAPSUQ) Natural Capsules Ltd Shs Dematerialised ISIN: INE936B01015 TV: TradingView: BSE: NATCAPSUQ SA: Stock Analysis: BOM: 524654 YF: Yahoo Finance: 524654.BO GF: Google Finance: BOM: 524654 BA: Barron's: 524654 MS: Morningstar: XBOM: 524654	156.00 INR	TV: TradingView: BSE: NATCAPSUQ SA: Stock Analysis: BOM: 524654 YF: Yahoo Finance: 524654.BO GF: Google Finance: BOM: 524654 BA: Barron's: 524654 MS: Morningstar: XBOM: 524654

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Natural Capsules Ltd.

Natural Capsules Limited engages in the manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy-free gelatin, shiny gelatin, sodium lauryl sulfate-free gelatin, halal-certified gelatin, fast-release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form. Natural Capsules Limited was incorporated in 1993 and is based in Bengaluru, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)

Name	Market Cap (USD) diff.	PE	Country
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 66K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 65K%	22.7	India
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.43B 807.02B INR 50K%	23.1	India
Cohance Lifesciences Ltd. NSE: SUVENPHAR	$1.87B 178.87B INR 11K%	199.0	India
Granules India Ltd. NSE: GRANULES	$1.83B 174.85B INR 11K%	32.1	India
Viyash Scientific Ltd. NSE: SEQUENT	$944.92M 90.48B INR 5K%	92.7	India

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 222K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 175K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 94K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 54K%	80.6	China
ABIVAX Société Anonyme EPA: ABVX	$8.79B 7.57B EUR 52K%	-	France
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.22B 35.33B CNY 31K%	20.0	China

chevron_leftBack